维普中文期刊产品整合服务
4篇 您的检索式:作者名="L.Irving"
    题名 作者 年代 出处 被引量
1医药领域美国专利法最新发展显示文摘专利是创新医药公司的生命线。专利的有效性对于创新医药公司的生存和在市场上的竞争力至关重要。因此,医药领域美国专利的非显而易见性(即创造性)的判定也成为一个广受关注的议题。Thomas L.Irving Stacy Lewis 王宁玲 2016进出口经理人2016,0,6:1
2Direct ex vivo comparison of the breadth and specificity of the T?cells in the liver and peripheral blood of patients with chronic HCV infection显示文摘Anna M.Grabowska FranziskaLechner PaulKlenerman Paddy J.Tighe StephenRyder Jonathan K.Ball Brian J.Thomson William L.Irving R. AdrianRobins 2001Eur J Immunol2001,,8:1
3Severe fibrosis in hepatitis C virus‐infected patients is associated with increased activity of the mannan‐binding lectin (MBL)/MBL‐associated serine protease 1 (MASP‐1) complex显示文摘K. S.Brown M. J.Keogh N.Tagiuri M. J.Grainge J. S.Presanis S. D.Ryder W. L.Irving J. K.Ball R. B.Sim T. P.Hickling 2006Clinical & Experimental Immunology2006,,1:1
4A new tool for estimating liver cancer risk after a hepatitis C virus cure显示文摘Chronic hepatitis C virus(HCV)infection frequently leads to liver cirrhosis(1),which is a major risk factor for hepatocellular carcinoma(HCC)and liver failure.Together,these two complications account for nearly half a million HCV-related deaths every year,world-wide(2).In contrast to other blood borne viruses such as HIV and hepatitis B,chronic HCV is a curable infection.Yet until recently,few HCV cirrhosis patients were able to achieve a cure because standard-of-care therapies were ineffective(<30%chance of cure)and entailed significant adverse effects(3).Hamish Innes William L.Irving 2020Hepatobiliary Surgery and Nutrition2020,9,6:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费